Fortis Malar Hospitals Ltd (FORTISMLR) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Fortis Malar Hospitals Ltd on NSE and BSE, with an AI summary of each filing.
Relevant Disclosures Attached
Financial Result · 03 Nov 2026, 8:35 pm
Fortis Malar Hospitals Reports Q2'27 Financial Results Fortis Malar Hospitals reported consolidated net profit of ₹28.08 lakh for the quarter ended 30th Sep'26, up from ₹15.22 lakh in Q1'27 and ₹1.42 lakh YoY. Consolidated revenue totaled ₹74.05 lakh, supported by ₹55.56 lakh in other income and ₹18.49 lakh in grant income. Total cash and bank balances stood at ₹3,633.25 lakh as of 30th Sep'26. Following the prior slump sale of its hospital operations, the company holds no active business operations and is evaluating corporate restructuring options while maintaining going-concern status.
Relevant Disclosures are Attached
Outcome · 03 Nov 2026, 8:29 pm
Fortis Malar Hospitals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 18.5 (+639.6% YoY | +20444.4% QoQ) ■ EBITDA: -23.0 (+38.4% YoY | +31.7% QoQ) ■ EBITDA Margin (%): -124 (+136702 bps YoY | +3720916 bps QoQ) ■ PAT: 28.1 (+1877.5% YoY | +84.5% QoQ) ■ EPS (INR): 0.15 (+1400.0% YoY | +87.5% QoQ)
The relevant disclosure is attached
Change in Management · 30 Oct 2026, 11:06 pm
Fortis Malar Hospitals Discloses Director Dr. Ritu Garg Resignation Details Fortis Malar Hospitals Limited submitted a regulatory disclosure to BSE under Regulation 30 detailing the resignation of Director Dr. Ritu Garg. Following her initial resignation letter dated 27th Oct'26, which took effect from the close of business hours on the same day, Dr. Garg formally cited "other commitments and responsibilities" as the reason for stepping down from the board. The event was recorded on 30th Oct'26 at 11:30 AM.
The relevant disclosure is attached.
Change in Management · 30 Oct 2026, 11:04 pm
Dr. Ritu Garg Resigns as Director of Fortis Malar Hospitals Fortis Malar Hospitals Limited announced that Dr. Ritu Garg has resigned from her position as Director, effective from the close of business hours on 27th Oct'26. In a regulatory clarification submitted on 30th Oct'26, the company cited other commitments and responsibilities as the reason for her departure.
Fortis Malar Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the Un audited Financial ....
Intimation · 03 Nov 2026, 5:30 am
Fortis Malar Hospitals Schedules Board Meeting for Q2 FY27 Results Approval Fortis Malar Hospitals has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve its standalone and consolidated unaudited financial results for the quarter and half year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed for designated persons until 48 hours following the results announcement, reopening after 5th Nov'26.
The relevant disclosure is attached.
Change in Management · 27 Oct 2026, 9:15 pm
Fortis Malar Hospitals Board Appoints Dr. S Narayani Following Dr. Ritu Garg Resignation Fortis Malar Hospitals Limited announced that Dr. Ritu Garg resigned from her role as Non-Executive Non-Independent Director effective 27th Oct'26 due to other commitments. Consequently, based on the Nomination and Remuneration Committee's recommendation, the Board approved the appointment of Dr. S Narayani as an Additional Director (Non-Executive Non-Independent, liable to retire by rotation) effective 27th Oct'26. Dr. Narayani brings over 25 years of healthcare experience and currently serves as Regional Director Operations – Mumbai, overseeing four hospitals.
The relevant disclsoure is attached.
Change in Management · 27 Oct 2026, 9:11 pm
Fortis Malar Hospitals Board Reconstitutes Non-Executive Directorship Fortis Malar Hospitals Limited announced that Dr. Ritu Garg resigned as Non-Executive Non-Independent Director effective 27th Oct'26 due to other commitments. Consequently, based on the Nomination and Remuneration Committee's recommendation, the Board approved the appointment of Dr. S Narayani (DIN: 06993476) as Non-Executive Non-Independent Director (liable to retire by rotation), effective 27th Oct'26. Dr. Narayani brings over 25 years of healthcare experience, currently serving as Regional Director Operations - Mumbai, overseeing four Fortis hospitals, and holds no relationships with other company directors.
Relevant Disclosure is attached
Financial Result · 04 Aug 2026, 8:16 pm
Fortis Malar Hospitals Reports Q1FY27 Financial Results Fortis Malar Hospitals reported Q1FY27 consolidated net profit of ₹15.22 lakhs for the quarter ended 30 Jun'26, compared to a loss of ₹4.50 lakhs in the previous quarter. Total consolidated income was ₹53.56 lakhs, a decline from ₹65.94 lakhs QoQ. The auditors' report noted the company has ceased business operations following a slump sale and is evaluating restructuring options. Management believes current cash is sufficient to meet obligations, and results have been prepared on a going concern basis. Basic EPS stood at ₹0.08.
Approval of Financial Results for the quarter ended June 30, 2026
Outcome · 04 Aug 2026, 8:08 pm
Fortis Malar Hospitals Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 0.1 (-95.6% YoY | -71.0% QoQ) ■ EBITDA: -33.6 (-4.3% YoY | +38.8% QoQ) ■ EBITDA Margin (%): -37,333 (-3576114 bps YoY | -1961398 bps QoQ) ■ PAT: 15.2 (-96.3% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.08 (-96.4% YoY | Loss to Profit QoQ)
The relevant disclosure is attached
Annual General Meeting · 30 Jul 2026, 1:14 am
Fortis Malar Hospitals Passes All Resolutions at 35th Annual General Meeting Fortis Malar Hospitals announced that all three resolutions proposed at its 35th AGM on 29-Jul'26 were passed with the requisite majority. Key resolutions included adopting audited financial statements for the year ended 31-Mar'26, re-appointing Mr. Daljit Singh as a director, and ratifying the cost auditors' remuneration. The total voter turnout represented 62.79% of total shareholding. All resolutions received over 99.98% of votes in favor. Promoters, holding 11.75 million shares, voted 100% in favor of all proposals.
The relevant disclosure is attached
Annual General Meeting · 30 Jul 2026, 12:52 am
Fortis Malar Hospitals Holds 35th Annual General Meeting to Approve Resolutions Fortis Malar Hospitals (BSE: 523696) held its 35th AGM on Jul 29, '26, chaired by Mr. Daljit Singh, with 81 members attending. Key resolutions included adopting the audited financial statements for the year ended Mar 31, '26, and re-appointing Mr. Daljit Singh as Director. Another resolution ratified the Cost Auditors' remuneration. The Statutory and Secretarial Auditor reports had no qualifications. Remote e-voting was conducted from Jul 24, '26, to Jul 28, '26, with voting results to be declared by Jul 31, '26.
Proceedings of 35th AGM
Annual General Meeting · 30 Jul 2026, 12:48 am
Fortis Malar Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve Un-audited Finacial ....
Intimation · 04 Aug 2026, 5:30 am
Fortis Malar Hospitals Sets Board Meeting for Q1 FY27 Results Fortis Malar Hospitals (Scrip: 523696) will hold a Board of Directors meeting on Aug 04, '26. The agenda includes consideration and approval of the un-audited standalone and consolidated financial results for the quarter ended Jun 30, '26. The trading window for dealing in the company's securities will remain closed until Aug 06, '26, which is 48 hours after the results announcement. This meeting is a key event for the upcoming earnings release for the first quarter of the fiscal year.
Relevant disclosure is attached.
Annual Report · 03 Jul 2026, 1:26 am
Annual Report for the Financial Year 2025-2026
Others (Uncategorized) · 03 Jul 2026, 1:23 am
Please find attached Notice of 35th Anuual General Meeting scheduled to be held on July 29, 2026
Annual General Meeting · 03 Jul 2026, 1:18 am
The relevant disclosure is attached .
Others (Uncategorized) · 05 Jun 2026, 6:05 pm
Fortis Malar Reports Status of Physical Share Transfer Requests for Mar'26 & Apr'26 Fortis Malar Hospitals submitted reports from its RTA, KFin Technologies, on physical share re-lodgement requests for Mar'26 and Apr'26. In Mar'26, 394 requests were received and processed; all 394 were rejected with an average processing time of 6 days. No requests were approved. In Apr'26, there were nil requests received, processed, approved, or rejected. This update complies with the SEBI circular dated Jan 30, 2026, providing a special window for such transfers.
Relevant disclosures attached
Others (Uncategorized) · 18 May 2026, 9:53 pm
Fortis Malar Hospitals Board Approves FY26 Results, Updates Corporate Policies The Board of Directors for Fortis Malar Hospitals (FMHL), on 18 May'26, approved the audited standalone and consolidated financial results for the quarter and year ended 31 Mar'26. Statutory auditors, B S R & Co. LLP, issued an unmodified audit report. The Board also adopted a modified policy for determining event materiality and an updated insider trading policy. Following a slump sale of business operations, the company has ceased business activities and is currently evaluating corporate restructuring options, though it believes it remains a going concern.
Relevant disclosures attached
Others (Uncategorized) · 18 May 2026, 9:33 pm
Fortis Malar Hospitals Approves FY26 Financials with Unmodified Auditor Opinion On 18 May'26, Fortis Malar Hospitals' board approved audited standalone and consolidated financial results for the quarter and year ended 31 Mar'26. Statutory auditors B S R & Co. LLP issued an unmodified opinion. The board also adopted revised policies for Materiality of Events and Insider Trading. An auditor's Emphasis of Matter notes the company has ceased business operations post a slump sale and is evaluating corporate restructuring options, though it remains a going concern based on its current cash position to meet obligations.
Relevant disclosures attached
Outcome · 18 May 2026, 9:29 pm
Fortis Malar Hospitals Board Approves FY26 Results, Updates Policies Fortis Malar Hospitals Limited's board approved the audited standalone and consolidated financial results for the quarter and year ended Mar'26. For FY26, the consolidated profit after tax stood at ₹413.74 lakhs on a total income of ₹635.29 lakhs. The auditor, B S R & Co. LLP, issued an unmodified opinion, noting the company has ceased business operations post a slump sale and is evaluating restructuring options. The board also adopted modified policies for Materiality of Events and Prevention of Insider Trading.
relevant disclosures attached
Financial Result · 18 May 2026, 9:24 pm
Fortis Malar Hospitals Approves FY26 Results, Auditor Highlights Slump Sale Impact Fortis Malar Hospitals' board, on 18 May'26, approved audited consolidated and standalone financial results for the quarter and year ended 31 Mar'26. For FY26, the company reported a consolidated net profit of ₹413.74 lakhs versus ₹39.20 lakhs YoY. The auditor, BSR & Co. LLP, issued an unmodified opinion but included an "Emphasis of Matter" noting the company has ceased business operations following a slump sale. While evaluating restructuring options, management believes it can meet obligations on a going concern basis. The board also approved updated corporate policies.
Fortis Malar Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Intimation · 18 May 2026, 5:30 am
Fortis Malar Hospitals Board Meeting Scheduled for Q4 & FY26 Results Fortis Malar Hospitals has scheduled a Board of Directors meeting for 18 May'26 to consider and approve the audited standalone and consolidated financial results for the quarter and fiscal year ended 31 Mar'26. Consequently, the trading window for dealing in the company's securities will remain closed until 20 May'26, which is 48 hours after the results are announced. This meeting is a key event for the release of the company's annual financial performance data.
The attached disclosure is an update on the demand raised by Income Tax Order Order for AY 2024-25
Others (Uncategorized) · 28 Mar 2026, 6:53 pm
Fortis Malar Hospitals Resolves Income Tax Demand for AY24-25 Fortis Malar Hospitals announced the successful resolution of an income tax matter for AY24-25. The company's rectification application against a tax demand of INR 20.82 Lakhs, raised by the Income Tax department, Bengaluru, has been processed. Following a CPC order dated 26th Mar'26, the demand was deleted, and a refund of INR 41.11 Lakhs has been determined. This event, which occurred on 27th Mar'26, results in a positive financial outcome for the company with no further expected liabilities from this specific case.
The relevant disclosure is attached.
Others (Uncategorized) · 25 Mar 2026, 7:30 pm
Fortis Malar Hospitals Receives Income Tax Demand of Rs. 48.2 Lakhs Fortis Malar Hospitals received an Income Tax rectification order on 24 Mar'26 for assessment year 2018-19, raising an additional demand of Rs. 48,22,435. The demand is related to interest under section 234D. Based on its assessment, the company believes the demand is not maintainable and is working on filing an appeal. Management does not envisage any material financial or operational impact from this order.
The relevant disclosure is attached.
Others (Uncategorized) · 17 Mar 2026, 12:33 am
Fortis Malar Reports Zero Physical Share Transfer Requests for Jan-Feb 2026 Fortis Malar Hospitals reported it received zero requests for the re-lodgement of physical share transfers for the months ending Jan'26 and Feb'26. The disclosure, dated 16th Mar'26, was made in compliance with SEBI circulars establishing a special window for such transactions. The company's Registrar and Share Transfer Agent, KFin Technologies, confirmed that no requests were received, processed, approved, or rejected during the specified periods. This indicates minimal activity related to physical share certificate transfers for the company during this window.